Expansion Therapeutics Overview
- Year Founded
-
2016
- Status
-
Out of Business
- Employees
-
24
- Latest Deal Type
-
Out of Business
Expansion Therapeutics General Information
Description
Provider of small molecule binders transformative oral medicines intended to treat severe RNa-mediated diseases. The company's technology is a portfolio of novel RNA-targeted drug candidates with activity across a broad number of disease indications, enabling medical companies to provide treatment options for patients.
Contact Information
Website
expansionrx.webflow.ioCorporate Office
- 555 Heritage Drive
- Suite 150
- Jupiter, FL 33458
- United States
Corporate Office
- 555 Heritage Drive
- Suite 150
- Jupiter, FL 33458
- United States
Expansion Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 4. Out of Business | 20-Oct-2022 | Completed | Out of Business | |||
| 3. Later Stage VC (Series B) | 29-Sep-2021 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 03-Jan-2018 | $5M | $5M | Completed | Generating Revenue | |
| 1. Accelerator/Incubator | Completed | Startup |
Expansion Therapeutics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B | ||||||||
| Series A |
Expansion Therapeutics Comparisons
Industry
Financing
Details
Expansion Therapeutics Competitors (38)
One of Expansion Therapeutics’s 38 competitors is NGM Biopharmaceuticals, a Private Equity-Backed company based in South San Francisco, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| NGM Biopharmaceuticals | Private Equity-Backed | South San Francisco, CA | ||||
| etherna | Formerly VC-backed | Niel, Belgium | ||||
| Sarepta Therapeutics | Formerly VC-backed | Cambridge, MA | ||||
| Sangamo Therapeutics | Formerly VC-backed | Richmond, CA | ||||
| Senti Biosciences Holdings | Formerly VC-backed | South San Francisco, CA |
Expansion Therapeutics Patents
Expansion Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4210703-A1 | Small molecules that target the rna that causes als | Pending | 08-Sep-2020 | ||
| EP-4210703-A4 | Small molecules that target the rna that causes als | Pending | 08-Sep-2020 | ||
| US-20240067639-A1 | Small molecules that target the rna that causes als | Pending | 08-Sep-2020 | ||
| WO-2022055922-A1 | Small molecules that target the rna that causes als | Inactive | 08-Sep-2020 | ||
| US-20200207744-A1 | Dimer compounds, and use in binding toxic repeats of rna | Inactive | 28-Dec-2018 | C07D235/18 |
Expansion Therapeutics Signals
Expansion Therapeutics FAQs
-
When was Expansion Therapeutics founded?
Expansion Therapeutics was founded in 2016.
-
Where is Expansion Therapeutics headquartered?
Expansion Therapeutics is headquartered in Jupiter, FL.
-
What is the size of Expansion Therapeutics?
Expansion Therapeutics has 24 total employees.
-
What industry is Expansion Therapeutics in?
Expansion Therapeutics’s primary industry is Drug Discovery.
-
Is Expansion Therapeutics a private or public company?
Expansion Therapeutics is a Private company.
-
What is Expansion Therapeutics’s current revenue?
The current revenue for Expansion Therapeutics is .
-
How much funding has Expansion Therapeutics raised over time?
Expansion Therapeutics has raised $85M.
-
Who are Expansion Therapeutics’s competitors?
NGM Biopharmaceuticals, etherna, Sarepta Therapeutics, Sangamo Therapeutics, and Senti Biosciences Holdings are some of the 38 competitors of Expansion Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process